Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JAMES J BENDELL

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Reproductive Endocrinology

NPI
1518071182
CMS profile
1231896
Location
LAGRANGE, GA

General Payments · PY2018–2024

$13,978.40

  • Reported across 140 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$4,835.52

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
INTUITIVE SURGICAL, INC. $4,659.35 4
COLOPLAST CORP $56.84 2
Sumitomo Pharma America, Inc. $32.82 2
Astellas Pharma US Inc $26.92 1
MAYNE PHARMA COMMERCIAL LLC $25.97 1
PFIZER INC. $20.02 1
Agile Therapeutics, Inc. $13.60 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,330.50 34
PY2019 $284.52 17
PY2020 $149.43 8
PY2021 $269.51 15
PY2022 $5,774.13 41
PY2023 $334.79 13
PY2024 $4,835.52 12

Payment records · PY2024 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Agile Therapeutics, Inc. $13.60 07/31/2024 Food and Beverage Undisputed 01/23/2026 1154844303 CMS
Astellas Pharma US Inc $26.92 05/20/2024 Food and Beverage Undisputed 01/23/2026 1139371475 CMS
COLOPLAST CORP $30.36 02/05/2024 Food and Beverage Undisputed 01/23/2026 1117438597 CMS
COLOPLAST CORP $26.48 10/24/2024 Food and Beverage Undisputed 01/23/2026 1117438685 CMS
INTUITIVE SURGICAL, INC. $4,000.00 02/02/2024 Education Undisputed 01/23/2026 1137074718 CMS
INTUITIVE SURGICAL, INC. $150.00 02/02/2024 Food and Beverage Undisputed 01/23/2026 1137293185 CMS
INTUITIVE SURGICAL, INC. $500.00 09/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1137217443 CMS
INTUITIVE SURGICAL, INC. $9.35 12/17/2024 Food and Beverage Undisputed 01/23/2026 1137203366 CMS
MAYNE PHARMA COMMERCIAL LLC $25.97 01/03/2024 Food and Beverage Undisputed 01/23/2026 1154690135 CMS
PFIZER INC. $20.02 09/16/2024 Food and Beverage Undisputed 01/23/2026 1131639952 CMS
Sumitomo Pharma America, Inc. $15.43 02/27/2024 Food and Beverage Undisputed 01/23/2026 1148826562 CMS
Sumitomo Pharma America, Inc. $17.39 06/17/2024 Food and Beverage Undisputed 01/23/2026 1148826564 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.